The A-VIVO score: a novel prognostic tool for predicting mortality in patients with sepsis
Der A-VIVO-Score: ein neuartiges Prognoseinstrument zur Vorhersage der Mortalität bei Patient:innen mit Sepsis
Irish Journal of Medical Science (1971 -) · 2026-10 · 195 (5) · 3063-3071
DOI: 10.1007/s11845-026-04475-z ↗Auf einen Blick
In einer retrospektiven Einzelzentrumsstudie war der A-VIVO-Score bei Nicht-Überlebenden höher und mit Mortalität assoziiert.
Fragestellung
Wie gut sagt der A-VIVO-Score die frühe Mortalität bei Patient:innen mit Sepsis voraus?
Methode
Retrospektive, monozentrische Beobachtungsstudie mit erwachsenen ICU-Patient:innen mit Sepsis nach Sepsis-3 zwischen Januar 2020 und Januar 2025; 30-Tage-Mortalität.
Ergebnisse
683 Patient:innen. 400 (58,6 %) starben innerhalb von 30 Tagen, 283 (41,4 %) überlebten. Der A-VIVO-Score war bei Nicht-Überlebenden signifikant höher und zeigte eine starke Assoziation mit Mortalität.
Schlussfolgerung der Autor:innen
Der A-VIVO-Score ist laut Autor:innen ein einfaches und praktisches Instrument zur Vorhersage der Mortalität bei Sepsis und könnte frühe klinische Entscheidungen unterstützen.
Kernaussagen
- A-VIVO-Score bei Nicht-Überlebenden höher
- 30-Tage-Mortalität: 58,6 %
- Monozentrische retrospektive Studie mit 683 Patient:innen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Beobachtungsstudie in der Zeitschrift Irish Journal of Medical Science (1971 -), online erschienen am 10.06.2026. Verfasst von Öztürk Taşkın und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Reanimation, Faculty of Medicine, Kastamonu University, Kastamonu, Türkiye. drozturk275@hotmail.com. Hauptthemen laut MEDLINE: Sepsis. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kastamonu University.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis is a life-threatening clinical syndrome associated with high morbidity and mortality in patients admitted to intensive care units. Early prediction of mortality risk is essential for timely interventions and optimal use of critical care resources. Although various prognostic scoring systems are available, many are complex or not easily applicable in daily clinical practice. Therefore, simple and reliable tools for early risk stratification are needed.
Aims
The aim of this study was to evaluate the prognostic performance of the A-VIVO score in predicting early mortality in patients with sepsis.
Methods
This retrospective, single-center observational study reviewed electronic medical records of adult patients diagnosed with sepsis according to the Sepsis-3 criteria and admitted to the intensive care unit between January 2020 and January 2025. Patients aged 18 years or older who were monitored for at least 48 h were included. Patients with missing data or unavailable mortality outcomes were excluded. Patients were classified as survivors or non-survivors based on 30-day mortality. The A-VIVO score was calculated using eight clinical and laboratory parameters, each scored from 0 to 2 points.
Results
A total of 683 patients were included. Of these, 400 patients (58.6%) died within 30 days, while 283 patients (41.4%) survived. The A-VIVO score was significantly higher in non-survivors and showed a strong association with mortality.
Conclusions
The A-VIVO score is a simple and practical tool for predicting mortality in patients with sepsis and may support early clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Reanimation, Faculty of Medicine, Kastamonu University, Kastamonu, Türkiye. drozturk275@hotmail.com.
- Department of Anesthesiology and Reanimation, Faculty of Medicine, Kastamonu University, Kastamonu, Türkiye.
- Intensive Care Clinic, Faculty of Medicine, Kastamonu University, Kastamonu, Türkiye.
- Department of Anesthesiology and Reanimation, Faculty of Medicine, İzmir Tınaztepe University, İzmir, Türkiye.
Förderung
- Kastamonu University
Zitieren
APA
Taşkın, Ö., Demi̇r, U., Soylu, V. G., Yılmaz, A., & Tanyıldızı Küçük, B. (2026). The A-VIVO score: a novel prognostic tool for predicting mortality in patients with sepsis. Irish Journal of Medical Science (1971 -), 195(5), 3063-3071. https://doi.org/10.1007/s11845-026-04475-z
Vancouver
Taşkın Ö, Demi̇r U, Soylu VG, Yılmaz A, Tanyıldızı Küçük B. The A-VIVO score: a novel prognostic tool for predicting mortality in patients with sepsis. Irish Journal of Medical Science (1971 -). 2026;195(5):3063-3071. doi:10.1007/s11845-026-04475-z
BibTeX
@article{Takn2026,
author = {Taşkın, Öztürk and Demi̇r, Ufuk and Soylu, Veysel Garani and Yılmaz, Ayşe and Tanyıldızı Küçük, Büşra},
title = {The A-VIVO score: a novel prognostic tool for predicting mortality in patients with sepsis},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2026},
volume = {195},
number = {5},
pages = {3063--3071},
doi = {10.1007/s11845-026-04475-z}
}
EUVIMED